Intrinsic Imaging Publishes Its Metrics Champion Consortium Imaging Performance Targets
Bolton, MA, San Antonio, TX September 29, 2010
Intrinsic Imaging LLC, an imaging core lab, publishes today its Metrics Champion Consortium Imaging Performance Targets.
“Intrinsic Imaging’s business model is entirely focused on optimizing the management and analysis of medical images during Phase I-IV clinical trials. Without compromising quality or regulatory compliance, we are able to achieve unprecedented operational targets due to our unique technology, our optimized business model and our in depth radiology expertise across all therapeutic areas.” said Todd A. Joron, BSc, MBA, President and COO, Intrinsic Imaging.
Intrinsic Imaging is a corporate sponsor of the Metrics Champion Consortium (MCC). The MCC’s mission is to develop performance metrics within the biotechnology and pharmaceutical industry with the intent to jointly encourage performance improvement, effectiveness, efficiency, and appropriate levels of controls for both Sponsors and Service Providers in support of the drug development process. The MCC Imaging Performance Metrics Steering Committee recently released V1.0 of its imaging metrics.
“With our team of more than sixty sub-specialized, board-certified radiologists, and through use of our innovative Clinical Imaging Management System from Merge Healthcare, we are able to streamline our medical imaging operations.” said Todd Tibbetts, M.D., Ph.D., Medical Director, Oncology at Intrinsic. “We are thereby able to manage medical images much more effectively and provide radiology review of images to Sponsors in a much shorter time period.”
For comparative purposes, Table 1 outlines select operational targets related to imaging acquisition, processing, queries and submissions. As presented, Intrinsic Imaging’s target metrics are significantly more aggressive than current MCC targets.
Intrinsic executives attribute these material differences to their unique ability to readily implement new best-of-breed technologies to enable faster and more cost effective management, analysis and reporting of medical images in clinical trials.
Table 2 provides a complete set of Intrinsic Imaging’s current operational targets. Intrinsic reports all of its MCC imaging metrics for each clinical trial and these are provided at no incremental cost to the Sponsor. Further, to demonstrate the Company’s commitment to attaining these targets, Intrinsic Imaging provides all Sponsors with service level agreements (SLAs) identifying these metrics as appropriate.
Table 1 – Selected Intrinsic Imaging Performance Targets vs MCC
|Metrics Champion Consortium (MCC)|
Imaging Performance Targets
|Average number of calendar days from image receipt to initial feedback to site|
|Average number of calendar days from image QC complete to reporting of eligibility results|
|Average number of calendar days from image receipt to ready for independent (radiologist) review|
|Average number of calendar days an imaging query is outstanding|
|Average number of calendar days from last patient reviewed (by a radiologist) to delivery of dataset|
Table 2 – Intrinsic Complete MCC v.1.0 Imaging Performance Targets
|MCC Category||MCC Metric Title|
|Financial||Average percentage of variance in the imaging budget|
|Contract Signature||Average number of calendar days from imaging study award to contract signature|
Depends on client . Intrinsic ready in < 5 days
|Site Start-Up||Percentage of sites qualified vs. actual|
|Site Start-Up||Average number of calendar days from site designated ready to first date of image receipt|
Protocol and site dependent
|Image Acquisition||Average number of calendar days from image acquisition to image receipt|
|Image Acquisition||Average number of calendar days from image receipt to initial feedback to site|
|Image Processing||Average number of calendar days from image QC complete to reporting of eligibility results|
|Image Processing||Average number of calendar days from image receipt to ready for independent (radiology) review|
|Image Processing||Average number of calendar days from when the image is designated for review to completion of the review|
|Image Quality||Percentage of suboptimal (but evaluable) images|
|Image Quality||Percentage of non-evaluable images versus total received|
|Image Quality||Percentage of non-evaluable baseline images|
|Missing Imaging||Percentages of missing imaging visits|
|Image Queries||Percentage of site queries|
|Image Queries||Average number of calendar days an imaging query is outstanding|
|Export Submission||Average number of calendar days from last patient reviewed to delivery of dataset|
|Export Submission||Average number of calendar days from original estimate to actual for export submission|
|Independent Review Charter||Number of weeks to develop and write independent review charter|
< 1 week
|Acquisition Protocol Robustness||Number of image acquisition technique-related amendments per modality per protocol|
About Intrinsic Imaging LLC
Located in Bolton, Massachusetts and San Antonio, Texas, Intrinsic Imaging is an FDA audited, ISO 9001, ISO 13485, ISO 22301 and ISO 27001 certified and GAMP5 compliant medical imaging core lab specializing in providing imaging core lab services for clinical trials. With its team of more than seventy board-certified fellowship trained radiologists, robust and scalable clinical imaging technologies and its ISO certified quality management systems, Intrinsic Imaging is ideally positioned to provide unprecedented imaging core lab services around the world.